Categories

Unambiguous HLA typing: why full-length typing is a game-changer

HLA typing is a critical component in multiple areas of modern medicine: organ and bone marrow transplantation, clinical immunology, pharmacogenomics, and personalized medicine. However, for years, laboratories have faced a significant limitation: ambiguity in the results, especially when using short-read NGS-based methodologies.


Today, the arrival of full-length HLA typing solutions using nanopore sequencing marks a turning point. In this article, we explore why full-length HLA typing eliminates ambiguities, improves resolution, and becomes a real and efficient alternative for clinical and research laboratories.

The historical problem of HLA typing: ambiguity

HLA genes are characterized by being highly polymorphic and structurally complex. When analyzed using short read technologies , the result is usually:

  • Partial gene coverage
  • Difficulty in assigning complete haplotypes
  • Ambiguous results that require further interpretation
  • Longer analysis and validation time

In fact, in many NGS-based workflows, a single analysis can generate dozens or even hundreds of possible allelic combinations , which complicates clinical decision-making.

What does “full-length” really mean in HLA typing?

Full-length HLA typing involves amplification and sequencing of the entire gene , from beginning to end, in a single continuous read.

Thanks to nanopore technology:

  • A single reading covers the entire gene.
  • Direct information is obtained from the haplotype
  • The need for complex bioinformatics reconstructions is eliminated.
  • The resolution is truly high definition

This represents a conceptual change: possible combinations are no longer inferred, they are read directly .

Nanopore vs traditional NGS: key differences

1. Resolution and accuracy

While traditional NGS fragments genetic information, nanopore sequencing allows:

  • Uniform coverage of HLA genes
  • Precise discrimination between very similar alleles
  • Polished data with qualities close to Q30

2. Elimination of ambiguities

In comparative studies, full-length HLA typing has shown:

  • Total reduction of ambiguities compared to NGS
  • Up to 891 ambiguities eliminated in direct comparison
  • Clear and directly interpretable results

3. More reliable clinical information

The ability to identify complete haplotypes improves confidence in critical applications such as:

  • Donor-recipient compatibility
  • HLA-disease association studies
  • Personalized medicine and patient stratification

Full-length HLA: real impact in the laboratory

Adopting a full-length HLA typing solution not only improves the end result, but also optimizes the entire workflow:

  • Less time spent resolving ambiguities
  • Less dependence on additional analyses
  • Results ready in less than a day
  • Scalability from 1 to 96 samples per run

Furthermore, automating typing reduces inter-operator variability and increases the reproducibility of the analysis.

A new standard for HLA typing

The evidence is clear: full-length HLA typing using nanopore is not an incremental evolution , but a paradigm shift.

For laboratories seeking:

  • High resolution
  • Unambiguous results
  • Speed and operational efficiency
  • Clinical confidence

Full-length HLA is positioned as the new technological standard.


Artículos recomendados

See all
V Interdisciplinary Congress on Human Genetics (AEGH)
V Interdisciplinary Congress on Human Genetics (AEGH)
The Proquinorte team will be present at the Granada Conference Centre for the 5th Interdisciplinary Congress on Human Genetics (AEGH), a key meeting point for professionals in the clinical, research and diagnostic fields.
PFAS: what they are and how to detect the “forever chemicals”
PFAS: what they are and how to detect the “forever chemicals”
PFAS (per- and polyfluoroalkyl substances) are a family of more than 3,000 synthetic compounds that have been used since the 1940s in sectors as diverse as the textile, food, automotive, and chemical industries. Among the best known are PFOA, PFOS, and GenX.
Advanced clinical analyses for the care of your pets
Advanced clinical analyses for the care of your pets
It's no surprise to many that the number of dogs in families has increased by 38%, according to Icart. This phenomenon reflects a reality: our pets are not only life companions, but they also require specific care to maintain their health in optimal condition. As Jeff Hamilton, Managing Director of Nestlé Purina Petcare in Europe, points out, "After a global pandemic, the number of pet owners and animal lovers worldwide is greater than ever, and the sector is responding by accelerating its innovation, offering greener, smarter, and better solutions than ever before."